Contents of the journal :   №59 (1) 2015

Biotechnological medicinal products and biosimilars: what clinicians should know when prescribing biosimilars
Authors: Talaeva T.V. Doroshchyk L.V. Kudriavtseva I.G. №59 (1) 2015 / Review: 12

The influence of TNF-α inhibitors on radiological progression in ankylosing spondylitis
Authors: Kovalenko V.M. Garmish E.A. Levchenko V.G. Romanovskiy A.V. №59 (1) 2015 / Review: 7

DIFFERENTIAL TREATMENT APPROACH KNEE OSTEOARTHRITIS ANTI-INFLAMMATORY DRUGS DEPENDING ON BONE MINERAL DENSITY
Authors: Shuba N.M. Tarasenko T.N. №59 (1) 2015 / Review: 8

The use of hyaluronic acid for the treatment of osteoarthritis
Authors: Kovalenko V.M. Bortkevych O.P. Boichuk N.S. №59 (1) 2015 / Review: 9

Piascledin® 300 efficacy in the management of osteoarthritis: proved in clinical trials, confirmed by European practice
Author:Bortkevych O.P. №59 (1) 2015 / Review: 10

The role of iatrogenic factor at pathologies caused by hereditary predisposition
Authors: Baburkina E.P. Simenach B.I. №59 (1) 2015 / Review: 11

Gout — multimorbid pathology
Authors: Shuba N.M. Voronova T.D. №59 (1) 2015 / Review: 15

Prevention of thromboembolic complications in patients with rheumatic heart disease
Author:Getman T.V. №59 (1) 2015 / Review: 12

Affected joints in systemic vasculitis
Authors: Syniachenko O.V. Iermolaieva M.V. Yehudina Ye.D. Sedaia L.V. №59 (1) 2015 / Review: 10

The features of immune response in patients with heart failure
Authors: Fedorov S.V. Glushko L.V. №59 (1) 2015 / Review: 9

THE INFLUENCE OF COMORBIDITY AND EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS ON THE EFFICACY AND TOLERABILITY OF SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS
Authors: Yaremenko O.B. Mykytenko G.M. №59 (1) 2015 / Review: 6

RHEUMATIC MANIFESTATIONS OF HEMOGLOBINOPATHIES
Authors: Kazymyrko V.K. Ivanitskaya L.N. Kutovyi V.V. Dubkova A.G.... №59 (1) 2015 / Review: 9

ACROMEGALIC ARTHROPATHY: EPIDEMIOLOGY, PATHOGENESIS, CLINICAL, DIAGNOSIS AND PROGNOSIS
Author:Kondratiuk V.Е. №59 (1) 2015 / Review: 12